BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 123534
Published online Oct 15, 2026. doi: 10.4251/wjgo.123534
Table 1 Clinicopathological comparison between intracholecystic papillary-tubular neoplasm and intraductal tubulopapillary neoplasm[4,6-12]
Feature
ICPN
ITPN
Age/sex tendencyUsually older adults; female predominanceUsually older adults; slight male predominance
Gross/imaging patternPolypoid or mass-forming intraluminal gallbladder lesion; may coexist with gallbladder wall thickening or suspected gallbladder cancerSolid or mixed solid-cystic intraductal pancreatic mass; ductal dilatation may be present, and the lesions may mimic other pancreatic cystic neoplasms
Histological architecturePapillary, tubular, or tubulopapillary architecture; heterogeneous epithelial lineages may include biliary, gastric, intestinal, and oncocytic phenotypesBack-to-back tubules, cribriform or abortive papillary structures, high-grade cytology, and minimal or absent mucin
Dysplasia/invasionLow- or high-grade dysplasia; invasive carcinoma may be present, but resected ICPN often has more a favorable prognosis than conventional gallbladder cancerHigh-grade dysplasia is characteristic; invasive carcinoma is common in resected series, but prognosis after resection is generally better than that of conventional pancreatic ductal adenocarcinoma
ImmunophenotypeVariable according to lineage; biliary-type lesions often express CK7 and MUC1, gastric-type lesions may express MUC5AC/MUC6, and intestinal-type lesions may express CDX2/CK20Typically MUC1 and MUC6 positive, MUC2 negative, and MUC5AC absent or limited
Molecular featuresHeterogeneous; reported alterations include KRAS, STK11, CTNNB1, APC, TP53, and lineage-associated changesKRAS/GNAS alterations are uncommon, whereas PI3K pathway alterations, chromatin-remodeling alterations, FGFR2 fusions, and rare ALK fusions have been reported
Clinical implicationSurgical resection is recommended when feasible; if invasive carcinoma is present, management should follow gallbladder cancer principles and pathologic stageSurgical resection is recommended when feasible; the invasive component, margin status, nodal status, and recurrence risk should guide surveillance


Write to the Help Desk